The Annual General Assembly of the French Pulmonary Hypertension Association HTaPFrance is taking place in Paris on Saturday the 6th of April 2024 in Paris.
The morning program is dedicated to the presentation of the annual report of activities, vote on financial report and approval of new members of the Board.
The afternoon program features a scientific program featuring experts from the “Centre de référence coordonnateur de l’hypertension pulmonaire, PulmoTension” (CHU Bicêtre, Le Kremlin-Bicêtre).
Here is a list:
- “Relabelling”: What is it about? – Prof. Marc Humbert, coordinating center PulmoTension, Bicêtre Hospital
- What is the purpose of the RespiFIL network? – Céline Lustremant, project manager of the RespiFIL network
- Update on treatments under development, reminder on clinical trials – Prof. Olivier Sitbon, Coordinating center PulmoTension, Bicêtre Hospital
- Understanding how doctors use risk scores in treatment decisions – Dr. Athénaïs Boucly, coordinating center PulmoTension
- Presentation of pumps for parenteral administration of prostanoids – VitalAire
- Indications for transplantation and pathway to transplantation – Dr. Jérôme Le Pavec, constitutive center PulmoTension, Marie Lannelongue Hospital
- Practical information on genetics of pulmonary arterial hypertension, especially in children: which genes? Who can be tested or not? Why and How? – Dr. Julien Grynblat, constitutive center PulmoTension, Necker Hospital
- Pulmonary arterial hypertension in adult congenital heart diseases – Dr. Sébastien Hascoët, constitutive center PulmoTension, Marie Lannelongue Hospital
- Pulmonary arterial hypertension in respiratory diseases – Dr. Ségolène Turquier, constitutive center PulmoTension, Louis Pradel Hospital, Lyon
- Low-salt diet – Mélody Georges, Dietician, constitutive center PulmoTension, Marie Lannelongue Hospital
- Fabienne Simon, HTaPFrance social service assistant, answering questions submitted via the Secretariat.
More details to follow after the meeting!
